These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 18462797)

  • 21. Significance and meaning of neurological signs in schizophrenia: two decades later.
    Bombin I; Arango C; Buchanan RW
    Schizophr Bull; 2005 Oct; 31(4):962-77. PubMed ID: 15958818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological soft signs in first-episode schizophrenia: a follow-up study.
    Bachmann S; Bottmer C; Schröder J
    Am J Psychiatry; 2005 Dec; 162(12):2337-43. PubMed ID: 16330599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?
    Prasad KM; Keshavan MS
    Schizophr Bull; 2008 Jul; 34(4):774-90. PubMed ID: 18408230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic bases for endophenotypes in psychiatric disorders.
    Berrettini WH
    Dialogues Clin Neurosci; 2005; 7(2):95-101. PubMed ID: 16262206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurobiological disturbances in schizophrenia].
    Glenthøj BY; Nordentoft M; Lublin H
    Ugeskr Laeger; 2008 Nov; 170(46):3784-6. PubMed ID: 19014733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological soft signs and brain morphology in first-episode schizophrenia.
    Thomann PA; Wüstenberg T; Santos VD; Bachmann S; Essig M; Schröder J
    Psychol Med; 2009 Mar; 39(3):371-9. PubMed ID: 18578894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological soft signs and cerebral measurements investigated by means of MRI in schizophrenic patients.
    Bersani G; Paolemili M; Quartini A; Clemente R; Gherardelli S; Iannitelli A; Di Biasi C; Gualdi G; Pancheri P
    Neurosci Lett; 2007 Feb; 413(1):82-7. PubMed ID: 17174477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent advances in the genetics of schizophrenia and the practical implications of the results].
    Réthelyi J; Polgár P; Czobor P; Bitter I
    Psychiatr Hung; 2008; 23(3):152-65. PubMed ID: 18956622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancing a functional genomics for schizophrenia: psychopathological and cognitive phenotypes in mutants with gene disruption.
    Kirby BP; Waddington JL; O'Tuathaigh CM
    Brain Res Bull; 2010 Sep; 83(3-4):162-76. PubMed ID: 19800398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates between neurological soft signs and saccadic parameters in schizophrenia.
    Picard HJ; Amado I; Bourdel MC; Landgraf S; Olié JP; Krebs MO
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):676-81. PubMed ID: 19303908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The psychopathology of schizophrenia and the presence of neurological soft signs: a review.
    Tosato S; Dazzan P
    Curr Opin Psychiatry; 2005 May; 18(3):285-8. PubMed ID: 16639153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endophenotypes in schizophrenia: a review of electrophysiological studies].
    Ishii R; Takahashi H; Kurimoto R; Aoki Y; Ikeda S; Hata M; Ikezawa K; Canuet L; Nakahachi T; Iwase M; Takeda M
    Seishin Shinkeigaku Zasshi; 2012; 114(6):629-46. PubMed ID: 22844814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: a review.
    Singh SM; Basu D
    Addict Biol; 2009 Jul; 14(3):298-309. PubMed ID: 18811679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiology and schizophrenic vulnerability: the N400 component as endophenotype candidate?].
    Cermolacce M; Micoulaud-Franchi JA; Faugere M; Naudin J; Besson M; Vion-Dury J
    Neurophysiol Clin; 2013 Apr; 43(2):81-94. PubMed ID: 23540257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological soft signs in schizophrenia: are they related to negative or positive symptoms, neuropsychological performance, and violence?
    Braun CM; Lapierre D; Hodgins S; Toupin J; Léveillé S; Constantineau C
    Arch Clin Neuropsychol; 1995 Nov; 10(6):489-509. PubMed ID: 14588905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurobiology of the early course of schizophrenia.
    Jindal RD; Keshavan MS
    Expert Rev Neurother; 2008 Jul; 8(7):1093-100. PubMed ID: 18590479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia.
    Neelam K; Garg D; Marshall M
    BMC Psychiatry; 2011 Aug; 11():139. PubMed ID: 21859445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility genes for schizophrenia: mutant models, endophenotypes and psychobiology.
    O'Tuathaigh CM; Desbonnet L; Moran PM; Waddington JL
    Curr Top Behav Neurosci; 2012; 12():209-50. PubMed ID: 22367925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?
    Bender S; Weisbrod M; Resch F
    J Neural Transm (Vienna); 2007 Sep; 114(9):1199-215. PubMed ID: 17514428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.